Detecting and monitoring Alzheimer’s disease (AD) is becoming increasingly important, stressing the need for clinically relevant outcome measures. Functional decline, as measured with instrumental activities of daily living (IADL) questionnaires, is such an outcome measure.
Click here to access the article. An OpenAthens login is required. Alternatively call 0161 291 5778 or email Academy Library for a copy of the article.